Akebia Therapeutics Inc. sell Global_Player
Start price
23.05.23
/
50%
€1.44
Target price
23.05.24
-
Performance (%)
-21.56%
End price
25.05.23
€1.13
Summary
This prediction ended on 25.05.23 with a price of €1.13. The price of Akebia Therapeutics Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.56%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Akebia Therapeutics Inc. | -3.779% | -3.779% | -73.229% | -37.997% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
According to Global_Player what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Sell Akebia Therapeutics Inc.